Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer

NCT03957902 is registered in ClinicalTrials.gov with Instituto de Investigación Sanitaria Aragón as lead sponsor.

NCT NCT03957902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03957902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer
Lead sponsor
Instituto de Investigación Sanitaria Aragón
Phase
Phase 2
Overall status
Recruiting
Start date
May 6, 2019
Completion date
June 30, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer